Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 71
Filter
2.
Nat Commun ; 8(1): 1001, 2017 10 17.
Article in English | MEDLINE | ID: mdl-29042554

ABSTRACT

Recently, nanocarriers that transport bioactive substances to a target site in the body have attracted considerable attention and undergone rapid progression in terms of the state of the art. However, few nanocarriers can enter the brain via a systemic route through the blood-brain barrier (BBB) to efficiently reach neurons. Here we prepare a self-assembled supramolecular nanocarrier with a surface featuring properly configured glucose. The BBB crossing and brain accumulation of this nanocarrier are boosted by the rapid glycaemic increase after fasting and by the putative phenomenon of the highly expressed glucose transporter-1 (GLUT1) in brain capillary endothelial cells migrating from the luminal to the abluminal plasma membrane. The precisely controlled glucose density on the surface of the nanocarrier enables the regulation of its distribution within the brain, and thus is successfully optimized to increase the number of nanocarriers accumulating in neurons.There are only a few examples of nanocarriers that can transport bioactive substances across the blood-brain barrier. Here the authors show that by rapid glycaemic increase the accumulation of a glucosylated nanocarrier in the brain can be controlled.


Subject(s)
Blood Glucose/metabolism , Blood-Brain Barrier/metabolism , Brain/metabolism , Drug Carriers/pharmacokinetics , Animals , Brain/blood supply , Drug Carriers/metabolism , Female , Glucose/metabolism , Glucose Transporter Type 1/metabolism , Glycosylation , Humans , Mice, Inbred BALB C , Micelles , Microscopy, Confocal , Nanoparticles/metabolism , Neurons/metabolism , Polymers/chemistry , Polymers/metabolism
3.
Eur J Neurol ; 23(2): 393-400, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26518457

ABSTRACT

BACKGROUND: Some patients with multiple system atrophy (MSA) require surgical interventions such as tracheostomy and aspiration prevention. Few studies have investigated the postoperative clinical course of MSA patients. The aim of this study was to determine a management strategy for dysphagia and respiratory disorder in MSA. METHODS: From 2001 to 2014, 18 MSA patients (13 males and 5 females, 52-76 years) underwent tracheostomy (TR, n = 11) or laryngeal closure (LC, n = 12). Five patients underwent LC following TR. Vocal fold impairment, the degree of dysphagia and pre/post-operative oral ingestion, and postoperative survival time were evaluated retrospectively. Swallowing function was assessed using the penetration aspiration scale (PAS). RESULTS: TR was performed due to respiratory disorder in seven patients and due to dysphagia in four patients. PAS scores ranged 1-8 in TR patients and 7-8 in LC patients. Seven of 11 patients who underwent TR displayed worsened PAS scores, and no patients displayed improved PAS scores following TR. All patients who underwent LC regained complete or partial oral intake after surgery. There were no significant differences in postoperative survival time between the two groups. CONCLUSIONS: Considering the impacts of TR and LC on survival time, postoperative feeding and swallowing, LC is a good option for treating MSA patients with dysphagia.


Subject(s)
Deglutition Disorders/surgery , Laryngoplasty , Multiple System Atrophy/surgery , Postoperative Complications/physiopathology , Tracheostomy , Aged , Deglutition Disorders/physiopathology , Female , Humans , Laryngoplasty/adverse effects , Male , Middle Aged , Tracheostomy/adverse effects , Treatment Outcome
4.
Allergy ; 70(8): 995-1003, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25945591

ABSTRACT

BACKGROUND: Chronic rhinosinusitis (CRS) can be classified into CRS with nasal polyps (CRSwNP) and CRS without nasal polyps (CRSsNP). CRSwNP displays more intense eosinophilic infiltration and the presence of Th2 cytokines. Mucosal eosinophilia is associated with more severe symptoms and often requires multiple surgeries because of recurrence; however, even in eosinophilic CRS (ECRS), clinical course is variable. In this study, we wanted to set objective clinical criteria for the diagnosis of refractory CRS. METHODS: This was a retrospective study conducted by 15 institutions participating in the Japanese Epidemiological Survey of Refractory Eosinophilic Chronic Rhinosinusitis (JESREC). We evaluated patients with CRS treated with endoscopic sinus surgery (ESS), and risk of recurrence was estimated using Cox proportional hazard models. Multiple logistic regression models and receiver operating characteristics curves were constructed to create the diagnostic criterion for ECRS. RESULTS: We analyzed 1716 patients treated with ESS. To diagnose ECRS, the JESREC scoring system assessed unilateral or bilateral disease, the presence of nasal polyps, blood eosinophilia, and dominant shadow of ethmoid sinuses in computed tomography (CT) scans. The cutoff value of the score was 11 points (sensitivity: 83%, specificity: 66%). Blood eosinophilia (>5%), ethmoid sinus disease detected by CT scan, bronchial asthma, aspirin, and nonsteroidal anti-inflammatory drugs intolerance were associated significantly with recurrence. CONCLUSION: We subdivided CRSwNP in non-ECRS, mild, moderate, and severe ECRS according to our algorithm. This classification was significantly correlated with prognosis. It is notable that this algorithm may give useful information to clinicians in the refractoriness of CRS before ESS or biopsy.


Subject(s)
Rhinitis/classification , Rhinitis/epidemiology , Sinusitis/classification , Sinusitis/epidemiology , Adult , Age Distribution , Age of Onset , Aged , Algorithms , Chronic Disease , Cohort Studies , Eosinophilia/immunology , Female , Humans , Incidence , Japan/epidemiology , Male , Middle Aged , Multivariate Analysis , Prognosis , Proportional Hazards Models , Retrospective Studies , Rhinitis/immunology , Risk Assessment , Severity of Illness Index , Sex Distribution , Sinusitis/immunology , Young Adult
5.
Rhinology ; 52(3): 246-51, 2014 09.
Article in English | MEDLINE | ID: mdl-25271530

ABSTRACT

AIM: To describe the features of chronic sinusitis associated with the use of tumour necrosis factor (TNF) inhibitors. METHODOLOGY: A retrospective review of the medical records between 2003 and 2011 revealed that five patients had developed chronic sinusitis after the start of TNF inhibitor administration and required rhinological evaluation and treatment. RESULTS: The incidence of refractory sinusitis associated with TNF inhibitors was approximately 2%. Of the five patients identified, four patients were medicated with etanercept and one with infliximab. The maxillary sinus was most commonly involved and cultures of the sinus discharge revealed Pseudomonas aeruginosa in three cases. Two patients showed improvement of sinusitis with antibiotic medication, despite the continuous use of TNF inhibitor, while in two other patients, sinusitis was resistant to antibiotic medication. Another patient who had developed recurrence of sinusitis after complete remission of previous chronic sinusitis by endoscopic sinus surgery showed remission only after cessation of TNF inhibitor. CONCLUSION: Chronic sinusitis associated with TNF inhibitors is considered to be a new disease entity, and it will become more common due to the increasing use of TNF inhibitors.


Subject(s)
Antibodies, Monoclonal/adverse effects , Antirheumatic Agents/adverse effects , Immunoglobulin G/adverse effects , Maxillary Sinusitis/etiology , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Adult , Arthritis, Rheumatoid/drug therapy , Chronic Disease , Disease Susceptibility/immunology , Etanercept , Female , Humans , Infliximab , Maxillary Sinusitis/diagnostic imaging , Middle Aged , Radiography , Receptors, Tumor Necrosis Factor , Retrospective Studies , Tumor Necrosis Factor-alpha/immunology
6.
Int Immunopharmacol ; 22(1): 242-7, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24998164

ABSTRACT

Upper airway viral infection in patients with airway allergy often exacerbates olfactory dysfunction, but the mechanism for this exacerbation remains unclear. Here, we examined the effects of respiratory syncytial virus (RSV) infection, in the presence or absence of airway allergy, on olfactory receptor neurons (ORNs) and their progenitors in mice. Immunohistological analyses revealed that cockroach allergen (CRA)-induced airway allergy alone did not affect the number of OMP(+) mature ORNs and SOX2(+) ORN progenitors. Intranasal RSV line 19 infection in allergy-free mice resulted in a transient decrease in SOX2(+) ORN progenitors without affecting OMP(+) ORNs. In contrast, the RSV-induced decrease in SOX2(+) ORN progenitors was exacerbated and prolonged in allergic mice, which resulted in eventual loss of OMP(+) ORNs. In the allergic mice, reduction of RSV in the olfactory epithelium was delayed as compared with allergy-free mice. These results suggest that ORN progenitors were impaired by RSV infection and that airway allergy exacerbated damage to ORN progenitors by reducing viral clearance.


Subject(s)
Hypersensitivity/immunology , Nasal Mucosa/immunology , Olfactory Receptor Neurons/physiology , Respiratory Syncytial Virus Infections/immunology , Respiratory Syncytial Viruses/immunology , Allergens/immunology , Animals , Cell Differentiation/immunology , Cockroaches , Female , Hypersensitivity/complications , Mice , Mice, Inbred BALB C , Nasal Mucosa/virology , Olfactory Receptor Neurons/virology , Respiratory Syncytial Virus Infections/complications , SOXB1 Transcription Factors/metabolism , Viral Load
7.
Clin Exp Allergy ; 44(5): 701-12, 2014.
Article in English | MEDLINE | ID: mdl-24931597

ABSTRACT

BACKGROUND: Chronic rhinosinusitis with nasal polyps is generally characterized by local Th2 inflammation and is categorized into two subtypes in Japan: eosinophilic chronic rhinosinusitis (similar to chronic rhinosinusitis with nasal polyps in western countries) and non-eosinophilic chronic rhinosinusitis (characterized by Th1-dominant inflammation). OBJECTIVE: To investigate local IgE production and class switch recombination to IgE in these two subtypes of chronic rhinosinusitis with nasal polyps. METHODS: The identity of IgE-positive cells was determined using double-immunofluorescent staining for IgE and cell-type-specific molecular markers. To investigate the local class switch recombination to IgE and IgE synthesis in the mucosa, we performed real-time polymerase chain reaction to examine the mRNA expression of Th2 cytokines and class-switch-related molecules, including IL-4, IL-5, IL-13, ε germline gene transcripts, IgE mature transcript, IgG mature transcript, RAG1, RAG2 and activation-induced cytidine deaminase in eosinophilic polyps, non-eosinophilic polyps and controls. RESULTS: The concentrations of total IgE and number of IgE-positive cells were significantly higher in the eosinophilic polyps compared with control and non-eosinophilic polyps. IgE-positive cells were predominantly mast cells in eosinophilic polyps and significantly correlated with the number of FcεR1-positive cells in the subepithelial layer. IL-5 and IL-13 mRNA and ε germline gene transcripts expression levels were significantly higher in eosinophilic polyps compared with control and non-eosinophilic polyps. In contrast, the number of plasma cells and the expression of IgG mature transcripts were increased in non-eosinophilic polyps compared with eosinophilic polyps. RAG2 mRNA was significantly increased in both eosinophilic and non-eosinophilic polyps compared with control mucosa. CONCLUSION AND CLINICAL RELEVANCE: The current study suggests local class switching to IgE, production of IgE and IgE localization to the surface of mast cells in eosinophilic chronic rhinosinusitis in the Japanese population. The difference in the IgE-related profiles between eosinophilic chronic rhinosinusitis and non-eosinophilic chronic rhinosinusitis suggests heterogeneity in the pathogenesis of chronic rhinosinusitis with nasal polyps.


Subject(s)
Immunoglobulin Class Switching/genetics , Immunoglobulin E/genetics , Immunoglobulin E/immunology , Nasal Polyps/etiology , Rhinitis/complications , Sinusitis/complications , Adult , Aged , B-Lymphocyte Subsets/immunology , B-Lymphocyte Subsets/metabolism , Chronic Disease , Cytokines/genetics , Cytokines/metabolism , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Eosinophils/immunology , Female , Gene Expression Regulation , Homeodomain Proteins/genetics , Homeodomain Proteins/metabolism , Humans , Immunoglobulin Class Switching/immunology , Immunoglobulin E/metabolism , Immunoglobulin G/genetics , Immunoglobulin G/immunology , Inflammation/immunology , Inflammation/metabolism , Leukocyte Count , Male , Middle Aged , Nasal Mucosa/immunology , Nasal Mucosa/metabolism , Nasal Mucosa/pathology , Nasal Polyps/diagnosis , Nuclear Proteins/genetics , Nuclear Proteins/metabolism , Phenotype , Receptors, IgE/genetics , Receptors, IgE/metabolism , Rhinitis/diagnosis , Sinusitis/diagnosis
8.
Scand J Med Sci Sports ; 24(5): 799-806, 2014 Oct.
Article in English | MEDLINE | ID: mdl-23730848

ABSTRACT

Previous studies have shown that blood flow-restricted low-intensity resistance training (BFR-RT) causes muscle hypertrophy while maintaining arterial function in young adults. We examined the effects of BFR-RT on muscle size and arterial stiffness in older adults. Healthy subjects (ages 61-84 years) were divided into BFR-RT (n = 9) or non-training control (CON; n = 10) groups. The BFR-RT group performed 20% and 30%, respectively, of one-repetition maximal (1-RM) knee extension and leg press exercises, 2 days/wk for 12 weeks. The BFR-RT group wore elastic cuffs (120-270 mmHg) on both legs during training. Magnetic resonance imaging-measured muscle cross-sectional area (CSA), 1-RM strength, chair stand (CS) test, and cardio-ankle vascular index testing (CAVI), an index of arterial stiffness, were measured before and 3-5 days after the final training session. Muscle CSA of the quadriceps (8.0%), adductors (6.5%), and gluteus maximus (4.4%), leg extension and leg press 1-RM strength (26.1% and 33.4%), and CS performance (18.3%) improved (P < 0.05) in the BFR-RT group, but not in the CON group. In CAVI testing, there were no changes in both two groups. In conclusion, BFR-RT improves muscle CSA as well as maximal muscle strength, but does not negatively affect arterial stiffness or humeral coagulation factors in older adults.


Subject(s)
Exercise/physiology , Quadriceps Muscle/anatomy & histology , Quadriceps Muscle/physiology , Resistance Training/methods , Vascular Stiffness , Aged , Aged, 80 and over , Exercise Test , Female , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Muscle Strength , Quadriceps Muscle/blood supply
9.
Scand J Med Sci Sports ; 24(1): 55-61, 2014 Feb.
Article in English | MEDLINE | ID: mdl-22734915

ABSTRACT

We examined the effects of blood flow-restricted, low-intensity resistance exercise (termed kaatsu) using an elastic band for resistance on muscle activation. Nine men performed triceps extension and biceps flexion exercises (four sets respectively) using an elastic band for resistance with blood flow restriction (BFR) or CON (unrestricted blood flow). During a BFR session, subjects wore pressure cuffs inflated to 170-260 mmHg on the proximal region of both arms. Surface electromyography (EMG) was recorded from the triceps brachii and biceps brachii muscles, and mean integrated EMG (iEMG) was analyzed. Blood lactate concentration was obtained before (Pre) and immediately after two exercises (Post). During triceps extension and biceps flexion exercises, muscle activation increased progressively (P < 0.05) under BFR (46% and 69%, respectively) but not under CON (12% and 23%, respectively). Blood lactate concentration at Post was higher (P < 0.05) under BFR than under CON (3.6 and 2.1 mmol/L, respectively). Blood lactate concentration at Post was significantly correlated with increased iEMG in both triceps extension (r = 0.65, P < 0.01) and biceps flexion exercises (r = 0.52, P < 0.05). We conclude that kaatsu training using elastic bands for resistance enhances muscle activation and may be an effective method to promote muscle hypertrophy in older adults or patients with a low level of activity.


Subject(s)
Arm/physiology , Muscle Contraction/physiology , Muscle, Skeletal/physiology , Regional Blood Flow/physiology , Resistance Training/methods , Adult , Arm/blood supply , Electromyography , Humans , Lactic Acid/blood , Male , Muscle, Skeletal/blood supply , Young Adult
10.
Gene Ther ; 19(12): 1141-9, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22189415

ABSTRACT

We previously demonstrated that an artificial protein, TAT-FNK, has antiapoptotic effects against cochlear hair cell (HC) damage caused by ototoxic agents when applied systemically. To examine the feasibility of topical protein therapy for inner ear disorders, we investigated whether gelatin sponge soaked with TAT-FNK and placed on the guinea pig round window membrane (RWM) could deliver the protein to the cochlea and attenuate aminoglycoside (AG)-induced cochlear damage in vivo. First, we found that the immunoreactivity of TAT-myc-FNK was distributed throughout the cochlea. The immunoreactivity was observed from 1-24 h after application. When Tat-FNK was applied 1 h before ototoxic insult (a combination of kanamycin sulfate and ethacrynic acid), auditory brainstem response threshold shifts and the extent of HC death were significantly attenuated. When cochlear organotypic cultures prepared from P5 rats were treated with kanamycin, TAT-FNK significantly reduced the extent of caspase-9 activation and HC death. These findings indicate that TAT-FNK topically applied on the RWM can enter the cochlea by diffusion and effectively prevent AG-induced apoptosis of cochlear HCs by suppressing the mitochondrial caspase-9 pathway.


Subject(s)
Aminoglycosides/toxicity , Apoptosis/drug effects , Cochlea/drug effects , Gene Products, tat/pharmacology , Labyrinth Diseases/prevention & control , Protein Serine-Threonine Kinases/pharmacology , Recombinant Fusion Proteins/administration & dosage , Administration, Topical , Animals , Caspase 9/metabolism , Cochlea/metabolism , Ethacrynic Acid/pharmacology , Ethacrynic Acid/toxicity , Evoked Potentials, Auditory, Brain Stem/drug effects , Gene Products, tat/administration & dosage , Guinea Pigs , Hair Cells, Auditory/drug effects , Kanamycin/pharmacology , Labyrinth Diseases/chemically induced , Neuroprotective Agents , Protein Serine-Threonine Kinases/administration & dosage , Rats , Recombinant Fusion Proteins/pharmacology , Round Window, Ear , Tumor Suppressor Proteins
11.
J Laryngol Otol ; 124(11): 1162-6, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20537207

ABSTRACT

OBJECTIVES: Upon direct inspection of surgically removed ossicles from the ears of patients with long-term post-mastoidectomy cavity problems, the extent of malleus destruction often appears greater in patients with a longer duration of cavity problems, whereas the extent of incus destruction does not appear to correlate with the duration of cavity problems. This study aimed to investigate this impression. MATERIALS AND METHODS: As a result of total middle-ear reconstruction, 41 ossicles (21 malleus and 20 incus bones) were obtained from 31 patients with post-mastoidectomy cavity problems. The ossicles were examined histopathologically, and the proportion of lamellar bone area to total bone area (expressed as percentage lamellar bone) was measured. We also calculated the inter-operation time, i.e. the time period between the previous mastoidectomy and the recent total middle-ear reconstruction; this parameter was used as an approximate measure of the duration of the patient's cavity problem. Correlations between percentage lamellar bone and inter-operation time were calculated for the two ossicles. RESULTS: The range of inter-operation times was seven to 65 years. We observed a correlation between percentage lamellar bone and inter-operation time for malleus bones (r = -0.512, p < 0.05), but not for incus bones. CONCLUSION: These results were in agreement with our pre-study impressions.


Subject(s)
Ear, Middle/surgery , Incus/pathology , Malleus/pathology , Mastoid/surgery , Otitis Media, Suppurative/complications , Otologic Surgical Procedures/adverse effects , Chronic Disease , Humans , Plastic Surgery Procedures/methods , Retrospective Studies , Time Factors
12.
Int J Pediatr Otorhinolaryngol ; 73(1): 153-8, 2009 Jan.
Article in English | MEDLINE | ID: mdl-19042035

ABSTRACT

The promontory stimulation test (PST) using a needle electrode has been used to evaluate the sense of the auditory nerve as a preoperative examination for cochlear implant in adults. Because this is a painful test, it is not suitable for children. It has been reported that children with inner ear anomaly showed poorer outcomes of hearing after cochlear implant. Electroaudiometry developed by Med-El Corporation, which is noninvasive, is a more suitable procedure for young children. Patients were three children less than five years old with inner ear anomaly. Two patients showed common cavity, and one showed narrow IAC with hypoplastic cochlear anomaly. By using Electroaudiometry, we analyzed electro-neural hearing of these children before cochlear implant, and compared their hearing after cochlear implant. Three children seemed to have residural electro-neural hearing because the dynamic range between stimulus level (SL) and uncomfortable level (UCL) was detected by using Electroaudiometry. After cochlear implant, their pure-tone audiograms showed moderate hearing thresholds, and their hearing detection and speech perception improved. These results suggest that Electroaudiometry is available for evaluating electro-neural hearing in young children with inner ear anomaly. It can provide useful information for a successful cochlear implant and evaluation of postoperative performances.


Subject(s)
Acoustic Stimulation , Audiometry/methods , Cochlear Implants , Hearing Loss/diagnosis , Acoustic Stimulation/instrumentation , Audiometry/instrumentation , Child, Preschool , Ear Canal , Electrodes , Facial Expression , Female , Hearing Loss/physiopathology , Hearing Loss/therapy , Humans , Male , Predictive Value of Tests
13.
Acta Otolaryngol ; 128(4): 465-72, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18368584

ABSTRACT

CONCLUSION: Although overall improvement was not so dramatic due to a lack of retention, session by session advancement of matching pitch for targeted MIDI (Musical Instrument Digital Interface) sound was predominantly obvious. It was proved that The YUBA Method worked to improve singing ability for patients with cochlear implants. OBJECTIVES: This study sought to verify whether or not the Yuba theory and method improved the singing ability of patients with cochlear implants. SUBJECTS AND METHODS: Based on diagnosis, the instructor experimented to improve matching pitch of singing for three patients with cochlear implants using The YUBA Method. The mean fundamental frequencies and standard deviation of singing were then compared with before and after instructions to patients. The instruction was given for over 40 days at the University of Tokyo Hospital. RESULTS: For each patient, the mean fundamental frequencies of their singing approached the mean MIDI specified frequencies as references for tests done in all three songs. Overall, the SD between fundamental frequencies of their singing and reference MIDI sounds became smaller.


Subject(s)
Auditory Perception/physiology , Cochlear Implants , Deafness/rehabilitation , Music , Voice Quality/physiology , Voice Training , Voice/physiology , Adult , Biofeedback, Psychology , Deafness/physiopathology , Female , Follow-Up Studies , Humans , Male , Retrospective Studies , Treatment Outcome
14.
Science ; 309(5733): 481-4, 2005 Jul 15.
Article in English | MEDLINE | ID: mdl-16020738

ABSTRACT

Mutations in mitochondrial DNA (mtDNA) accumulate in tissues of mammalian species and have been hypothesized to contribute to aging. We show that mice expressing a proofreading-deficient version of the mitochondrial DNA polymerase g (POLG) accumulate mtDNA mutations and display features of accelerated aging. Accumulation of mtDNA mutations was not associated with increased markers of oxidative stress or a defect in cellular proliferation, but was correlated with the induction of apoptotic markers, particularly in tissues characterized by rapid cellular turnover. The levels of apoptotic markers were also found to increase during aging in normal mice. Thus, accumulation of mtDNA mutations that promote apoptosis may be a central mechanism driving mammalian aging.


Subject(s)
Aging/physiology , Apoptosis , DNA, Mitochondrial/genetics , Mutation , Oxidative Stress , Amino Acid Substitution , Animals , Caspase 3 , Caspases/metabolism , Cloning, Molecular , DNA Damage , DNA Fragmentation , DNA Polymerase gamma , DNA-Directed DNA Polymerase/genetics , Gene Targeting , Humans , Hydrogen Peroxide/metabolism , Lipid Peroxidation , Liver/metabolism , Mice , Mitochondria, Heart/metabolism , Mitochondria, Liver/metabolism , Muscle, Skeletal/metabolism , Myocardium/metabolism , Phenotype , Presbycusis/etiology , Reactive Oxygen Species/metabolism
15.
Neuroreport ; 12(18): 4013-7, 2001 Dec 21.
Article in English | MEDLINE | ID: mdl-11742230

ABSTRACT

This study shows distributions of lacZ-positive cells in the vestibular labyrinthine explants of young guinea pigs with mature ears. When adenovirus lacZ vectors were administered to the vestibular labyrinth following removal of the otoconial membrane, lacZ-positive cells were observed in the mesothelial cells in the perilymphatic space, in the sensory and supporting cells in the utricle and ampulla, and in the transitional and dark cells in the ampulla. When the otoconial membrane was preserved, lacZ-positive cells were not distributed in the utricular sensory epithelium. These findings suggest that adenovirus vectors can transform a variety of vestibular epithelial cells, but that it is difficult for adenovirus vectors to pass through the otoconial membrane.


Subject(s)
Adenoviridae/genetics , Ear, Inner/cytology , Genetic Vectors , Transfection/methods , Animals , Cells, Cultured , Ear, Inner/physiology , Guinea Pigs , In Vitro Techniques , Lac Operon , Saccule and Utricle/cytology , Saccule and Utricle/physiology , Transplants
16.
J Neurol Sci ; 187(1-2): 69-75, 2001 Jun 15.
Article in English | MEDLINE | ID: mdl-11440747

ABSTRACT

The incidence of auditory disturbances in vertebrobasilar insufficiency (VBI) is considered much rarer than vestibular disturbances, but no routine audiometric test results for VBI patients have been published. To determine the incidence of deafness associated with VBI and the sites predominantly involved in deafness, we studied 70 vertiginous patients with VBI using a routine audiological examination and magnetic resonance imaging (MRI). MRI detected a lacunar infarct involving the cochlear nuclei in one patient, but lacunae did not involve central auditory structures in the other patients. Twenty-five patients experienced tinnitus, deafness, or both, during vertigo episodes. Audiological examinations confirmed the development of unilateral deafness in 15 (21%) patients, involving the cochlea in 14 and cochlear nuclei in one. These findings indicate that hearing loss occurs in approximately one-fifth of VBI patients, much less frequently than vestibular disturbances, and that deafness associated with VBI mainly involves the cochlea.


Subject(s)
Auditory Pathways/blood supply , Basilar Artery/physiopathology , Brain Stem/blood supply , Deafness/etiology , Ear, Inner/blood supply , Vertebrobasilar Insufficiency/complications , Aged , Aged, 80 and over , Audiometry , Auditory Pathways/pathology , Auditory Pathways/physiopathology , Basilar Artery/pathology , Brain Stem/pathology , Brain Stem/physiopathology , Cochlear Nucleus/blood supply , Cochlear Nucleus/pathology , Cochlear Nucleus/physiopathology , Deafness/pathology , Deafness/physiopathology , Ear, Inner/pathology , Ear, Inner/physiopathology , Evoked Potentials, Auditory, Brain Stem/physiology , Female , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Vertebrobasilar Insufficiency/pathology , Vertebrobasilar Insufficiency/physiopathology , Vertigo/etiology , Vertigo/pathology , Vertigo/physiopathology
17.
Hear Res ; 146(1-2): 28-34, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10913881

ABSTRACT

The generation of reactive oxygen species (ROS) is thought to be part of the mechanism underlying noise-induced hearing loss (NIHL). Glutathione (GSH) is an important cellular antioxidant that limits cell damage by ROS. In this study, we investigated the effectiveness of a GSH supplement to protect GSH-deficient animals from NIHL. Pigmented guinea pigs were exposed to a 4 kHz octave band noise, 115 dB SPL, for 5 h. Group 1 had a normal diet, while groups 2, 3 and 4 were fed a 7% low protein diet (leading to lowered tissue levels of GSH) for 10 days prior to noise exposure. One hour before, immediately after and 5 h after noise exposure, subjects received either an intraperitoneal injection of 5 ml/kg body weight of 0.9% NaCl (groups 1 and 2), 0.4 M glutathione monoethyl ester (GSHE; group 3) or 0.8 M GSHE (group 4). Auditory thresholds were measured by evoked brain stem response at 2, 4, 8, 12, 16 and 20 kHz before and after noise exposure. Ten days post exposure, group 1 showed noise-induced threshold shifts of approximately 20 dB at 2, 16 and 20 kHz and 35 to 40 dB at other frequencies. Threshold shifts in group 2 were significantly greater than baseline at 2, 4, 16 and 20 kHz. GSHE supplementation in a dose-dependent fashion attenuated the threshold shifts in the low protein diet animals. Hair cell loss, as evaluated with cytocochleograms, was consistent with the auditory-evoked brainstem response results. Group 2 exhibited significantly more hair cell loss than any of the other groups; hair cell loss in group 3 was similar to that seen in group 1; group 4 showed less loss than group 1. These results indicate that GSH is a significant factor in limiting noise-induced cochlear damage. This is compatible with the notion that ROS generation plays a role in NIHL and that antioxidant treatment may be an effective prophylactic intervention.


Subject(s)
Antioxidants/pharmacology , Glutathione/pharmacology , Hearing Loss, Noise-Induced/prevention & control , Animals , Antioxidants/metabolism , Auditory Threshold/drug effects , Dietary Proteins/administration & dosage , Glutathione/deficiency , Glutathione/metabolism , Guinea Pigs , Hearing Loss, Noise-Induced/etiology , Hearing Loss, Noise-Induced/metabolism , Male , Organ of Corti/pathology , Reactive Oxygen Species/metabolism
18.
Hear Res ; 146(1-2): 134-42, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10913890

ABSTRACT

The protective efficacy of neurotrophin-3 (NT-3) and brain-derived neurotrophic factor (BDNF) at 1 or 10 microg/ml was assessed in guinea pigs exposed to 4 kHz octave band noise at 115 dB SPL for 5 h. BDNF, NT-3 or artificial perilymph was delivered to the scala tympani via a mini-osmotic pump, beginning 4 days prior to noise exposure and continuing for 1 week post-exposure. Protection was assessed physiologically by the change in auditory brainstem response (ABR) threshold, and histologically by outer hair cell (OHC) survival. There was a statistically significant increase in OHC survival and a decrease in ABR threshold shift in animals receiving NT-3 at a concentration of 10 microg/ml. In animals receiving 1 microg/ml NT-3, there was a significant increase in OHC survival in the first row of OHC, but no significant change in ABR threshold, relative to control animals. In animals treated with BDNF, no significant functional or histological protection was observed. The protection afforded by NT-3 (10 microg/ml) treatment was similar in magnitude to that reported previously with glial cell line-derived neurotrophic factor and suggests that several factors may be involved in the protective response.


Subject(s)
Brain-Derived Neurotrophic Factor/pharmacology , Hair Cells, Auditory, Outer/drug effects , Hair Cells, Auditory, Outer/injuries , Hearing Loss, Noise-Induced/prevention & control , Nerve Growth Factors , Neurotrophin 3/pharmacology , Noise/adverse effects , Animals , Brain-Derived Neurotrophic Factor/physiology , Cell Survival/drug effects , Evoked Potentials, Auditory, Brain Stem/drug effects , Glial Cell Line-Derived Neurotrophic Factor , Guinea Pigs , Hearing Loss, Noise-Induced/pathology , Hearing Loss, Noise-Induced/physiopathology , Nerve Tissue Proteins/pharmacology , Nerve Tissue Proteins/physiology , Neurotrophin 3/physiology , Receptors, Nerve Growth Factor/physiology
19.
Hear Res ; 142(1-2): 41-55, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10748327

ABSTRACT

We examined the effectiveness of glial cell line-derived neurotrophic factor (GDNF) to attenuate cochlear damage from intense noise stress. Subjects were exposed to 115 dB SPL one octave band noise centered at 4 kHz for 5 h. They received artificial perilymph with or without GDNF into the left scala tympani at 0.5 microliter/h from 4 days before noise exposure through 8 days following noise exposure. Different concentrations of GDNF (1 ng/ml, 10 ng/ml, 100 ng/ml, and 1 microgram/ml) were applied chronically directly into the guinea pig cochlea via a microcannula and osmotic pump. Noise-induced hearing loss was assessed with pure tone auditory brainstem responses (at 2, 4, 8 and 20 kHz), measured prior to surgery, 1 day before noise exposure, and 7 days following noise exposure. Subjects were killed on day 8 following exposure for histological preparation and quantitative assessment of hair cell (HC) damage. A dose-dependent protective effect of GDNF on both sensory cell preservation and hearing function was found in the treated ears. At 1 ng/ml, GDNF showed no significant protection; at 10 ng/ml, GDNF showed significant HC protection; and at 100ng/ml, it was greater and bilateral. At 1 microgram/ml, GDNF appeared to have a toxic effect under noise stress in some cochleae. These findings indicate that GDNF at certain concentrations can effectively protect the inner ear from noise-induced hearing loss.


Subject(s)
Cochlea/drug effects , Hearing Loss, Noise-Induced/prevention & control , Nerve Growth Factors , Nerve Tissue Proteins/therapeutic use , Animals , Cell Line , Dose-Response Relationship, Drug , Evoked Potentials, Auditory, Brain Stem/drug effects , Glial Cell Line-Derived Neurotrophic Factor , Guinea Pigs , Hair Cells, Auditory/drug effects , Hair Cells, Auditory/pathology , Hearing/drug effects , Hearing Loss, Noise-Induced/pathology , Nerve Tissue Proteins/adverse effects , Noise/adverse effects , Recombinant Proteins/adverse effects , Recombinant Proteins/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...